The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
The ILH–IITH Bioengineering Centre of Excellence was inaugurated on Wednesday at the Hyderabad campus in collaboration with ...
In a major breakthrough in cardiac care, doctors in Thiruvananthapuram have successfully performed the first Impella-assisted angioplasty in South Kerala, saving the life of a 38-year-old patient ...
Cryotherapy Market OverviewThe Cryotherapy Market is projected to grow at a rate of around 7% by 2028, driven by rising incidences of sports injuries and cancer, continuous technological advancements, ...
A final option, less commonly used, is a technique called atherectomy. This treatment uses a device that cuts or grinds away the hardened deposition (atheroma) within the artery. Atherectomy is less ...
This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.
For high-risk patients, the method could offer a safer alternative to open-heart surgery.
In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.
Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, ...
Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...
Robotic surgery is reshaping modern medicine. A combination of robotics and advanced imaging technologies allows surgeons to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results